{"address1": "Science Park", "address2": "2 Snunit St. POB 455", "city": "Karmiel", "zip": "2161401", "country": "Israel", "phone": "972 4 902 8100", "fax": "972 4 988 9489", "website": "https://www.protalix.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Funda\u00e7\u00e3o Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Karmiel, Israel.", "fullTimeEmployees": 213, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dror  Bashan", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 1376823, "exercisedValue": 0, "unexercisedValue": 175781}, {"maxAge": 1, "name": "Mr. Eyal  Rubin M.B.A.", "age": 49, "title": "Senior VP, CFO, Treasurer & Corporate Secretary", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 686779, "exercisedValue": 0, "unexercisedValue": 82031}, {"maxAge": 1, "name": "Mr. Yaron  Naos", "age": 60, "title": "Senior Vice President of Operations", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 513819, "exercisedValue": 0, "unexercisedValue": 79688}, {"maxAge": 1, "name": "Ms. Yael  Fellous", "title": "Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.56, "open": 2.56, "dayLow": 2.5, "dayHigh": 2.585, "regularMarketPreviousClose": 2.56, "regularMarketOpen": 2.56, "regularMarketDayLow": 2.5, "regularMarketDayHigh": 2.585, "payoutRatio": 0.0, "beta": 0.725, "trailingPE": 63.5, "forwardPE": 4.096774, "volume": 458497, "regularMarketVolume": 458497, "averageVolume": 698186, "averageVolume10days": 591270, "averageDailyVolume10Day": 591270, "bid": 2.48, "ask": 2.79, "bidSize": 9, "askSize": 22, "marketCap": 198202800, "fiftyTwoWeekLow": 0.82, "fiftyTwoWeekHigh": 2.76, "priceToSalesTrailing12Months": 3.7117324, "fiftyDayAverage": 2.4356, "twoHundredDayAverage": 1.5839, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 168898768, "profitMargins": 0.05491, "floatShares": 59149480, "sharesOutstanding": 78032600, "sharesShort": 650638, "sharesShortPriorMonth": 4787415, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0083, "heldPercentInsiders": 0.13697, "heldPercentInstitutions": 0.06027, "shortRatio": 0.99, "shortPercentOfFloat": 0.0087, "impliedSharesOutstanding": 78032600, "bookValue": 0.57, "priceToBook": 4.4561405, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": 2932000, "trailingEps": 0.04, "forwardEps": 0.62, "lastSplitFactor": "1:10", "lastSplitDate": 1576800000, "enterpriseToRevenue": 3.163, "enterpriseToEbitda": 32.35, "52WeekChange": 1.048387, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 2.54, "targetHighPrice": 15.0, "targetLowPrice": 14.0, "targetMeanPrice": 14.5, "targetMedianPrice": 14.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 34830000, "totalCashPerShare": 0.446, "ebitda": 5221000, "totalDebt": 5526000, "quickRatio": 1.492, "currentRatio": 2.345, "totalRevenue": 53399000, "debtToEquity": 12.788, "revenuePerShare": 0.736, "returnOnAssets": 0.03102, "returnOnEquity": 0.07637, "grossProfits": 29080000, "freeCashflow": 5434375, "operatingCashflow": 8674000, "revenueGrowth": 0.737, "grossMargins": 0.54458, "ebitdaMargins": 0.097770005, "operatingMargins": 0.39571, "financialCurrency": "USD", "symbol": "PLX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -0.781249, "regularMarketPrice": 2.54, "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "shortName": "Protalix BioTherapeutics, Inc. ", "corporateActions": [], "preMarketTime": 1743598040, "regularMarketTime": 1743537600, "exchange": "ASE", "messageBoardId": "finmb_941520", "exchangeTimezoneName": "America/New_York", "market": "us_market", "averageDailyVolume3Month": 698186, "fiftyTwoWeekLowChange": 1.72, "fiftyTwoWeekLowChangePercent": 2.0975611, "fiftyTwoWeekRange": "0.82 - 2.76", "fiftyTwoWeekHighChange": -0.22000003, "fiftyTwoWeekHighChangePercent": -0.079710156, "fiftyTwoWeekChangePercent": 104.83871, "dividendDate": 1576800000, "earningsTimestamp": 1742208603, "earningsTimestampStart": 1746707400, "earningsTimestampEnd": 1747053000, "earningsCallTimestampStart": 1742214600, "earningsCallTimestampEnd": 1742214600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.04, "epsForward": 0.62, "fiftyDayAverageChange": 0.10439992, "fiftyDayAverageChangePercent": 0.042864148, "twoHundredDayAverageChange": 0.9561, "twoHundredDayAverageChangePercent": 0.6036366, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 895239000000, "preMarketChange": 0.07800007, "preMarketChangePercent": 3.070869, "preMarketPrice": 2.618, "regularMarketChange": -0.02, "regularMarketDayRange": "2.5 - 2.585", "fullExchangeName": "NYSE American", "marketState": "PRE", "longName": "Protalix BioTherapeutics, Inc.", "displayName": "Protalix BioTherapeutics", "trailingPegRatio": null}